CME GROUP INC CLASS A (CME)

Sector: Financials

    Home/Companies/CME/Annual Meeting

2026 Annual Meeting Analysis

CME GROUP INC CLASS A · Meeting: May 14, 2026

Policy v1.2high confidenceView Filing ↗
For informational purposes only. This AI-generated analysis applies a published voting policy to publicly available proxy filings. It does not constitute investment advice, proxy voting advice, or a solicitation of any kind. AI analysis may be incomplete or inaccurate — always review the actual filing and make your own independent decision.

Directors FOR

14

Directors AGAINST

0

Say on Pay

FOR

Auditor

FOR

Director Elections

Election of Equity Directors

14 FOR
✓ FOR
Terrence A. Duffy

CME's 3-year price return of 86.4% outpaces the XLF sector ETF by +22.6 percentage points, well below the 65pp threshold needed to trigger a vote against under the strong-positive TSR tier; no overboarding, attendance, or independence concerns apply.

✓ FOR
Kathryn Benesh

Joined in 2023 (within 24 months of the meeting), so the TSR trigger does not apply; brings strong audit and financial services credentials as a CPA and former Deloitte audit partner with 40 years of experience.

✓ FOR
Timothy S. Bitsberger

No TSR trigger fires (CME outperforms XLF by only +22.6pp, far below the 65pp threshold); brings deep financial markets experience including senior roles at U.S. Treasury and TCW Group.

✓ FOR
Charles P. Carey

No TSR trigger fires given CME's strong positive returns well within the 65pp allowance; brings long tenure in derivatives industry leadership including as former Chairman of CBOT and now serves as independent Lead Director.

✓ FOR
Bryan T. Durkin

No TSR trigger fires; brings over 30 years of operational and regulatory experience at CME Group and CBOT covering technology, clearing, and market regulation.

✓ FOR
Harold Ford Jr.

Joined in 2023 (within 24 months), so the TSR trigger does not apply; brings relevant financial services, government relations, and public policy experience through roles at PNC, Morgan Stanley, and Merrill Lynch as well as 10 years in Congress.

✓ FOR
Martin J. Gepsman

No TSR trigger fires; brings deep institutional knowledge of CME's exchange operations and regulatory functions accumulated over more than 30 years as a member and board director.

✓ FOR
Daniel G. Kaye

No TSR trigger fires; serves as audit committee financial expert with 35 years at Ernst & Young and current audit committee chair roles at two other public companies, providing strong financial oversight credentials.

✓ FOR
Phyllis M. Lockett

No TSR trigger fires; brings entrepreneurial leadership, technology, and strategy experience relevant to CME's innovation initiatives, and serves on the Federal Home Loan Bank of Chicago board.

✓ FOR
Deborah J. Lucas

No TSR trigger fires; brings MIT-based academic expertise in derivatives, fixed income, and government financial policy directly relevant to CME's core business and regulatory environment.

✓ FOR
Rahael Seifu

No TSR trigger fires; brings technology, privacy, cybersecurity, and corporate governance expertise from her senior legal roles at Google, directly relevant to CME's operational risk focus.

✓ FOR
William R. Shepard

No TSR trigger fires; brings decades of experience as a futures commission merchant founder and long-time market participant, with specialized expertise in clearing house oversight.

✓ FOR
Howard J. Siegel

No TSR trigger fires; brings over 35 years of trading experience and deep knowledge of CME's clearing house risk management as long-time co-chair and now chair of the clearing house oversight committee.

✓ FOR
Dennis A. Suskind

No TSR trigger fires; brings extensive risk management and financial markets expertise as a retired Goldman Sachs general partner and prior Lead Director, chairing CME's risk committee since its inception in 2014.

CME's 3-year price return of 86.4% outperforms the XLF sector ETF benchmark by +22.6 percentage points, far below the 65pp threshold required to trigger a vote against any director under the strong-positive TSR tier; no directors are overboarded, have attendance issues, or raise independence concerns, and the board discloses a comprehensive skills matrix — all 14 equity director nominees receive a FOR vote.

Say on Pay

✓ FOR

CEO

Terrence A. Duffy

Total Comp

$23,394,854

Prior Support

N/A

CEO Terrence Duffy's total compensation of approximately $23.4 million is consistent with benchmarks for a CEO of a $108 billion market cap financial services firm with record revenue and earnings; pay mix is strongly performance-oriented, with roughly 85% of total pay variable (55% in equity awards and 30% in annual cash bonus tied to a cash earnings target that required 114% achievement to generate the actual payout). The company's 3-year stock return of 86.4% and TSR of approximately 22% in 2025 alone reflects strong alignment between executive pay outcomes and shareholder results, with performance share awards requiring the company to rank in the top half of S&P 500 companies by TSR to earn target payout and the 2023-2025 awards paying out at 200% after CME reached the 78.8th TSR percentile. The company maintains a meaningful clawback policy compliant with Dodd-Frank, robust stock ownership requirements, and anti-hedging and anti-pledging policies, all supporting a FOR vote.

Auditor Ratification

✓ FOR

Auditor

Ernst & Young LLP

Tenure

N/A

Audit Fees

$8,122,159

Non-Audit Fees

$193,105

Non-audit fees (tax services of $193,105) represent only about 2.4% of audit fees ($8,122,159), well below the 50% threshold that would raise independence concerns; auditor tenure is not disclosed in the proxy so the tenure trigger cannot fire per policy; Ernst & Young is a Big 4 firm fully appropriate for a company of CME's size and complexity.

Overall Assessment

CME Group's 2026 annual meeting presents a straightforward ballot: the company delivered record 2025 financial performance with strong TSR that clears all director election benchmarks, executive pay is heavily performance-linked and aligned with shareholder outcomes, and the auditor relationship raises no independence concerns. The most notable governance items are four charter amendments proposing to eliminate Class B shareholders' special director election rights — a meaningful step toward simplified, one-class governance that deserves shareholder support.

Filing date: March 23, 2026·Policy v1.2·high confidence